Current antiviral strategies for controlling cytomegalovirus in hematopoietic stem cell transplant recipients: prevention and therapy
- 1 September 1999
- journal article
- review article
- Published by Wiley in Transplant Infectious Disease
- Vol. 1 (3) , 165-178
- https://doi.org/10.1034/j.1399-3062.1999.010305.x
Abstract
Cytomegalovirus (CMV) remains a cause of significant morbidity and mortality after hematopoietic stem cell transplantation (HSCT). Ganciclovir prophylaxis, or preemptive treatment based on detection ...Keywords
This publication has 63 references indexed in Scilit:
- Late Cytomegalovirus Pneumonia in Adult Allogeneic Blood and Marrow Transplant RecipientsClinical Infectious Diseases, 1999
- A comparison of the pattern of interstitial pneumonitis following allogeneic bone marrow transplantation before and after the introduction of prophylactic ganciclovir therapy in 1989Bone Marrow Transplantation, 1998
- Outcome of Cord-Blood Transplantation from Related and Unrelated DonorsNew England Journal of Medicine, 1997
- Screening for CMV-specific T cell proliferation to identify patients at risk of developing late onset CMV diseaseBone Marrow Transplantation, 1997
- Cytomegalovirus pp65 Antigenemia after Autologous Marrow and Peripheral Blood Stem Cell TransplantationThe Journal of Infectious Diseases, 1996
- Failure of High-Dose Acyclovir to Prevent Cytomegalovirus Disease after Autologous Marrow TransplantationThe Journal of Infectious Diseases, 1995
- CYTOMEGALOVIRUS PNEUMONIA AFTER BONE MARROW TRANSPLANTATIONTransplantation, 1993
- Cytomegalovirus viraemia and specific T‐helper cell responses as predictors of disease after allogeneic marrow transplantationBritish Journal of Haematology, 1993
- Polymerase chain reaction to evaluate antiviral therapy for cytomegalovirus diseaseThe Lancet, 1991
- Immunosuppressive Effects of Ganciclovir on in Vitro Lymphocyte ResponsesThe Journal of Infectious Diseases, 1987